Literature DB >> 16275421

Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.

Lutz Lüdemann1, Wolfgünter Grieger, Reinhard Wurm, Peter Wust, Claus Zimmer.   

Abstract

The spatial properties and function of the tumor vasculature differ with the tumor type and grade. T1-weighted dynamic contrast-enhanced imaging technique enables the simultaneous quantification of some functional parameters of the vasculature. These are the fractional contrast-enhancing volumes of the tissue compartments (blood volume and leakage/extravascular extracellular volume) and the exchange parameters (perfusion and permeability). The relatively long monitoring duration of 12 min used here made it necessary to divide the extravascular extracellular compartment into two subcompartments, a slowly and a fast enhancing one with different permeabilities. Forty-one gliomas (WHO grades II-IV), six meningiomas and eight distant metastases were investigated. It was shown that the technique noninvasively provides information for separating different tumor types and characterizing their microenvironment. Fast permeability describes vessel permeability and was significantly increased in meningiomas as compared with intra-axial tumors. The corresponding volume of the fast enhancing compartment was significantly increased in meningiomas compared to all gliomas taken together. Slow permeability describes diffusion within the extravascular extracellular space and was significantly reduced in low-grade gliomas, indicating short diffusion distances. The slowly enhancing extravascular extracellular space was found to be increased in high-grade gliomas and distant metastases. Blood volume differed significantly among some tumor entities and glioma grades. Perfusion was shown to increase linearly with blood volume for volumes of up to 20%, flattening out thereafter. The scatter plots of extravascular extracellular volume and blood volume were shown to differ among the tumor entities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275421     DOI: 10.1016/j.mri.2005.06.007

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  24 in total

Review 1.  Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors.

Authors:  Hemant Sarin
Journal:  Ther Deliv       Date:  2010-08

2.  Radiation injury versus malignancy after stereotactic radiosurgery for brain metastases: impact of time-dependent changes in lesion morphology on MRI.

Authors:  Sabine Wagner; Heinrich Lanfermann; Gerrit Eichner; Hubert Gufler
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

3.  Candidate biomarkers of extravascular extracellular space: a direct comparison of apparent diffusion coefficient and dynamic contrast-enhanced MR imaging--derived measurement of the volume of the extravascular extracellular space in glioblastoma multiforme.

Authors:  S J Mills; C Soh; C J Rose; S Cheung; S Zhao; G J M Parker; A Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-22       Impact factor: 3.825

4.  Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.

Authors:  Andrés Server; Tone E Døli Orheim; Bjørn A Graff; Roger Josefsen; Theresa Kumar; Per H Nakstad
Journal:  Neuroradiology       Date:  2010-07-13       Impact factor: 2.804

Review 5.  Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours.

Authors:  G Thompson; S J Mills; D J Coope; J P B O'Connor; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

6.  Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer.

Authors:  Grégory Kuchcinski; Emilie Le Rhun; Alexis B Cortot; Elodie Drumez; Romain Duhal; Maxime Lalisse; Julien Dumont; Renaud Lopes; Jean-Pierre Pruvo; Xavier Leclerc; Christine Delmaire
Journal:  Eur Radiol       Date:  2017-02-16       Impact factor: 5.315

7.  Enhancing fraction in glioma and its relationship to the tumoral vascular microenvironment: A dynamic contrast-enhanced MR imaging study.

Authors:  S J Mills; C Soh; J P B O'Connor; C J Rose; G Buonaccorsi; S Cheung; S Zhao; G J M Parker; A Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-17       Impact factor: 3.825

8.  Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model.

Authors:  Peter Jantscheff; Vittorio Ziroli; Norbert Esser; Ralph Graeser; Jessica Kluth; Alena Sukolinskaya; Lenka A Taylor; Clemens Unger; Ulrich Massing
Journal:  Clin Exp Metastasis       Date:  2009-09-26       Impact factor: 5.150

9.  Glioma vessel abnormality quantification using time-of-flight MR angiography.

Authors:  Maddalena Strumia; Wilfried Reichardt; Ori Staszewski; Dieter Henrik Heiland; Astrid Weyerbrock; Irina Mader; Michael Bock
Journal:  MAGMA       Date:  2016-04-20       Impact factor: 2.310

10.  Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence.

Authors:  Friso W A Hoefnagels; Frank J Lagerwaard; Esther Sanchez; Cornelis J A Haasbeek; Dirk L Knol; Ben J Slotman; W Peter Vandertop
Journal:  J Neurol       Date:  2009-03-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.